AzTrials
AzTrials

Psychological StressNCT03840109

Emotional Support Messages Following a Cancer Diagnosis

An observational study of Psychological Stress and Anxiety, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychological Stress, Anxiety
What is being tested?
Questionnaire 1a, Questionnaire 1b and Questionnaire 2a
How many people
417 participants
Where
1 siteUnited States
Study dates
30 Jan 2019to 24 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Adult cancer patients

Who may be able to join

  • Participants must be 18 years of age or older
  • Participants with a diagnosis of breast, prostate, thoracic or digestive cancer in the past 3 years
  • Participants consented to Moffitt's Total Cancer Care (TCC) protocol and indicating a willingness to be contacted for future research by including an email contact.
  • Ability to read and write fluently in English

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 33612

Other trials in United States

About this study

Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. The messages with negative statements also differ based on whether the negative statements occur at the start or end of the message. After viewing the message, participants have the opportunity to rate the effectiveness of the message, to what extent the message made them feel better, and to what extent the message affects how they view the message provider as a useful source of emotional support.

Being tested
Questionnaire 1a, Questionnaire 1b, Questionnaire 2a, Questionnaire 2b, Questionnaire 3a
Keywords
emotional support, cancer
Medical subject headings
Stress, Psychological, Anxiety Disorders, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire 1aBehavioural

    Participants will be randomly shown two versions of messages in which the last 20% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 1bBehavioural

    Participants will be randomly shown two versions of messages in which the first 20% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 2aBehavioural

    Participants will be randomly shown two versions of messages in which the last 40% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 2bBehavioural

    Participants will be randomly shown two versions of messages in which the first 40% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 3aBehavioural

    Participants will be randomly shown two versions of messages in which the last 60% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 3bBehavioural

    Participants will be randomly shown two versions of messages in which the first 60% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 4aBehavioural

    Participants will be randomly shown two versions of messages in which the last 80% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

  • Questionnaire 4bBehavioural

    Participants will be randomly shown two versions of messages in which the first 80% of the message consists of negative statements of criticism and rate of the effectiveness of the message.

Study groups in NCT03840109
Study groupRoleWhat they receive
All ParticipantsAll participants will take an online questionnaire which includes their evaluation of one of 18 different emotional support messages randomly assigned through the Qualtrics survey system. The participants answer a series of closed ended scales regarding quality of the support message, supporter's competence, amount of emotional improvement they experienced after reading the message, and likelihood to seek support from the person writing the message.
Receives: Behavioral: Questionnaire 1a; Behavioral: Questionnaire 1b; Behavioral: Questionnaire 2a; Behavioral: Questionnaire 2b; Behavioral: Questionnaire 3a; Behavioral: Questionnaire 3b; Behavioral: Questionnaire 4a; Behavioral: Questionnaire 4b

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Message Effectiveness Scale

    Perceptions of message effectiveness will be tested through 4 ANOVA models that will test for differences between participants who received different messages in terms of perceived message effectiveness.

    Measured: Through study completion, up to 1 year

  2. Affective Improvement Scale

    Perceptions of message effectiveness will be tested through 4 ANOVA models that will test for differences between participants who received different messages in terms of self-reports of emotional improvement.

    Measured: Through study completion, up to 1 year

Secondary outcomes (2)
  1. Supporter Competence Scale

    Perceptions of message effectiveness will be tested through 4 ANOVA models that will test for differences between participants who received different messages in terms of perceptions of supporter competence.

    Measured: Through study completion, up to 1 year

  2. Likelihood of Seeking Support Scale

    Perceptions of message effectiveness will be tested through 4 ANOVA models that will test for differences between participants who received different messages in terms of their likelihood to seek support from the supporter in the future.

    Measured: Through study completion, up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2019
  2. Study start30 Jan 2019
  3. Primary completion10 May 2019
  4. Study completion24 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
417 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03840109
Sponsor's protocol ID
MCC-19957
Status last verified
Nov 2020
First submitted
11 Feb 2019
Last updated
25 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Psychological Stress and Anxiety, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Message Effectiveness Scale (time frame: Through study completion, up to 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in